Royalty Pharma (RPRX) Interest Coverage Ratio (2019 - 2026)

Royalty Pharma has disclosed Interest Coverage Ratio across 8 years of filings, most recently posting 1.42 for Q2 2026.

• In Q2 2026, Interest Coverage Ratio fell 53.46% year-over-year to 1.42; the TTM figure through Jun 2026 stood at 4.19 (down 39.45% YoY), while the FY2025 annual figure was 5.07, down 11.56% from the prior year.
• Interest Coverage Ratio came in at 1.42 for Q2 2026 at Royalty Pharma, down from 6.01 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 12.97 in Q4 2023 to a low of 10.28 in Q4 2022.
• Average Interest Coverage Ratio over 5 years is 4.82, with a median of 5.33 recorded in 2023.
• Year-over-year, Interest Coverage Ratio slumped 414.73% in 2022 and jumped 590.76% in 2025.
• Over 5 years, Interest Coverage Ratio stood at 10.28 in 2022, then surged by 226.18% to 12.97 in 2023, then plunged by 57.61% to 5.5 in 2024, then declined by 24.98% to 4.12 in 2025, then tumbled by 65.52% to 1.42 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 1.42 in Q2 2026, 6.01 in Q1 2026, and 4.12 in Q4 2025.